Billy R. Dehart v. HHS - Influenza, Guillain-Barre Syndrome (GBS) (2020)
Case summary [AI summaries can sometimes make mistakes]
Billy R. Dehart filed a petition on April 13, 2020, alleging that he suffered Guillain-Barre Syndrome (GBS) as a result of an influenza vaccine administered on September 22, 2014.
He stated that the vaccine was administered in the United States, that he suffered residual effects for more than six months, and that there had been no prior award or settlement. The respondent denied that petitioner sustained a GBS Table injury or that the vaccine caused his GBS and residual effects.
Despite these positions, the parties filed a joint stipulation on April 7, 2020, agreeing to a settlement. Chief Special Master Brian H.
Corcoran adopted the stipulation, awarding Billy R. Dehart a lump sum of $130,000.00 for all items of damages.
This amount represents compensation for all damages available under the Vaccine Act. The decision was issued on May 14, 2020.
Petitioner was represented by David Lee Wallace, and respondent was represented by Jennifer Leigh Reynaud.
Theory of causation
Petitioner alleged that he suffered Guillain-Barre Syndrome (GBS) as a result of an influenza vaccine administered on September 22, 2014. The respondent denied that petitioner sustained a GBS Table injury or that the vaccine caused his GBS and residual effects. The parties filed a joint stipulation agreeing to a settlement. The public decision does not describe the specific mechanism of causation, expert testimony, or detailed clinical facts. Chief Special Master Brian H. Corcoran adopted the stipulation, awarding a lump sum of $130,000.00 for all items of damages. The decision date was May 14, 2020. Petitioner was represented by David Lee Wallace, and respondent was represented by Jennifer Leigh Reynaud.
Source PDFs
USCOURTS-cofc-1_17-vv-00870